FR3080858B1 - Facteur de croissance cellulaire d'origine non animale et son utilisation - Google Patents

Facteur de croissance cellulaire d'origine non animale et son utilisation Download PDF

Info

Publication number
FR3080858B1
FR3080858B1 FR1853844A FR1853844A FR3080858B1 FR 3080858 B1 FR3080858 B1 FR 3080858B1 FR 1853844 A FR1853844 A FR 1853844A FR 1853844 A FR1853844 A FR 1853844A FR 3080858 B1 FR3080858 B1 FR 3080858B1
Authority
FR
France
Prior art keywords
growth factor
animal origin
cellular growth
cellular
origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1853844A
Other languages
English (en)
Other versions
FR3080858A1 (fr
Inventor
Hugues Gatto
Jean-Noel Thorel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naos Institute of Life Science SAS
Original Assignee
Naos Institute of Life Science SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naos Institute of Life Science SAS filed Critical Naos Institute of Life Science SAS
Priority to FR1853844A priority Critical patent/FR3080858B1/fr
Priority to EP19728488.8A priority patent/EP3788137A1/fr
Priority to CN201980044347.7A priority patent/CN112368367A/zh
Priority to PCT/FR2019/051016 priority patent/WO2019211567A1/fr
Publication of FR3080858A1 publication Critical patent/FR3080858A1/fr
Application granted granted Critical
Publication of FR3080858B1 publication Critical patent/FR3080858B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0043Medium free of human- or animal-derived components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/16Magnesium; Mg chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/35Polyols, e.g. glycerin, inositol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/44Thiols, e.g. mercaptoethanol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90Polysaccharides
    • C12N2501/905Hyaluronic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR1853844A 2018-05-04 2018-05-04 Facteur de croissance cellulaire d'origine non animale et son utilisation Active FR3080858B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1853844A FR3080858B1 (fr) 2018-05-04 2018-05-04 Facteur de croissance cellulaire d'origine non animale et son utilisation
EP19728488.8A EP3788137A1 (fr) 2018-05-04 2019-05-02 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation
CN201980044347.7A CN112368367A (zh) 2018-05-04 2019-05-02 包含α-硫辛酸或α-硫辛酸盐、维生素C衍生物和透明质酸的组合物及其用途
PCT/FR2019/051016 WO2019211567A1 (fr) 2018-05-04 2019-05-02 Composition comprenant de l'acide alpha-lipoique ou l'un de ses sels, un derive de vitamine c et de l'acide hyaluronique et son utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1853844 2018-05-04
FR1853844A FR3080858B1 (fr) 2018-05-04 2018-05-04 Facteur de croissance cellulaire d'origine non animale et son utilisation

Publications (2)

Publication Number Publication Date
FR3080858A1 FR3080858A1 (fr) 2019-11-08
FR3080858B1 true FR3080858B1 (fr) 2022-05-13

Family

ID=62874975

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1853844A Active FR3080858B1 (fr) 2018-05-04 2018-05-04 Facteur de croissance cellulaire d'origine non animale et son utilisation

Country Status (1)

Country Link
FR (1) FR3080858B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895680B1 (fr) * 2005-12-29 2011-03-18 Jean Noel Thorel Traitement therapeutique et/ou cosmetique d'une partie superficielle du corps humain, avec une base nutritive complexe
FR2926461B1 (fr) * 2008-01-23 2010-03-05 Jean Noel Thorel Nouveau facteur de croissance cellulaire d'origine non animale et applications
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes

Also Published As

Publication number Publication date
FR3080858A1 (fr) 2019-11-08

Similar Documents

Publication Publication Date Title
ES1253690Y (es) Sistema de indumentaria quirúrgica y método de uso
IL277337A (en) Antibodies against alpha signal modulatory protein and methods of use
IL273918A (en) Trispecific proteins and methods of use
IL278821A (en) Anti-SIRPA antibodies and methods of using them
SG11202010909RA (en) Anti-msr1 antibodies and methods of use thereof
JP2018172409A5 (ja) 15−hepeを含む組成物および同組成物を使用する方法
IL279587A (en) Protein tyrosine phosphatase inhibitors and methods of using them
IL270214A (en) Anti-sortilin antibodies and methods of using them
SG11202013170RA (en) Pd1-4-1bbl variant fusion protein and methods of use thereof
MA52797A (fr) Inhibiteurs de masp -2 et procédés d'utilisation
IL277404A (en) C3-binding substances and methods of using them
IL287282A (en) Anti-mertk antibodies and methods of using them
CL2020002333A1 (es) Anticuerpos anti-klk5 y métodos de uso.
IL290741A (en) Antibodies against cd-96 and methods of using them
IL280103A (en) Fusion protein containing SIRPalpha-4-1BBL and methods of using it
SG11202108734VA (en) Anti-trem2 antibodies and methods of use thereof
KR102404611B9 (ko) 짧은 시퀀스 신호의 그룹화 및 사용
IL289952A (en) Anti-ms4a4a antibodies and methods of using them
IL283884A (en) Antibodies against il-36 and methods of using them
IL280338A (en) Anti-SIGLEC-5 antibodies and methods of using them
IL285401A (en) Anti-clec2d antibodies and methods of using them
IL284475A (en) Multiple value test and methods for using it
IL276053A (en) Therapeutic Gard and methods of its use
FR3080858B1 (fr) Facteur de croissance cellulaire d'origine non animale et son utilisation
IL308260A (en) Antibodies against Tigit and methods of using them

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20191108

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

CL Concession to grant licences

Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR

Effective date: 20230724

AU Other action affecting the ownership or exploitation of an industrial property right

Effective date: 20231016

CL Concession to grant licences

Name of requester: NAOS, FR

Effective date: 20231016

Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR

Effective date: 20231016